Reuters logo
Boston Scientific to pay J&J $600 mln to settle Guidant suit
2015年2月17日 / 晚上9点59分 / 3 年前

Boston Scientific to pay J&J $600 mln to settle Guidant suit

Feb 17 (Reuters) - Medical device maker Boston Scientific Corp on Tuesday said it has agreed to pay $600 million to Johnson & Johnson to settle a long-running breach of merger lawsuit over Boston Scientific’s 2005 acquisition of rival Guidant.

J&J, which agreed to permanently dismiss its action without acknowledgment of liability by Guidant, had sought more than $7 billion in damages after it lost a bidding war to Boston Scientific following an initial deal to buy Guidant for $21.5 billion.

The Guidant acquisition was widely considered by Wall Street to be a disaster for Boston Scientific as it left the company laden with debt and dealing with a host of Guidant product recalls. Many analysts believed J&J had dodged a bullet by losing Guidant.

Boston Scientific said it expects to record a pre-tax litigation-related charge of about $600 million in its fourth quarter 2014 results. (Reporting by Bill Berkrot; Editing by Grant McCool)

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below